| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 106326-29-8 | Z-Lys(Z)-Ser-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 37178-11-3 | Z-Lys(Boc)-Leu-OMe |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 40908-35-8 | Z-Leu-Tyr-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 17263-42-2 | Z-LEU-TYR-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 40290-56-0 | Z-Leu-Ser-OMe |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 13171-96-5 | Z-Leu-Phe-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 18830-16-5 | Z-Leu-Met-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 42537-96-2 | Z-Leu-Ile-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 2706-38-9 | Z-Leu-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 167698-68-2 | Z-Leu-Arg-Gly-Gly-AMC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 156192-32-4 | Z-Leu-Arg-AMC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 2817-13-2 | Z-Leu-Ala-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 41487-00-7 | Z-Ile-Val-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 13211-37-5 | Z-Ile-Pro-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 13254-07-4 | Z-Ile-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 38972-95-1 | Z-Ile-Leu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 42538-01-2 | Z-Ile-Ile-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 13254-04-1 | Z-Ile-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | 106172-66-1 | Z-His-Val-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 13053-63-9 | Z-His-Tyr-Tyr-OEt |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 15574-28-4 | Z-His-Phe(4-NO2)-Phe-OMe |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 13053-69-5 | Z-His-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 13056-37-6 | Z-His-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 13056-38-7 | Z-His-Ala-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 2227211-00-7 | AS-1763 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | | AS-0141 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | | TAM16 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 1173755-55-9 | Eteplirsen(AVI-4658 Exondys 51) |
≥98% | | 询价 |
| 29 | 923950-08-7 | Dulaglutide(Trulicity LY2189265) |
≥98% | | 询价 |
| 30 | 1420706-45-1 | Patisiran(Onpattro) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 1772578-74-1 | Cenegermin(oxervate) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 1492984-65-2 | Inotersen(Tegsedi) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 1639325-43-1 | Givosiran(ALN-AS1 WHO-10280 Givlaari) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 1422959-91-8 | Golodirsen(Vyondys 53 SRP-4053) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 867331-82-6 | TG 100801 |
≥98% | | 询价 |
| 36 | 1664293-06-4 | ITIC |
≥98% | | 询价 |
| 37 | 89213-87-6 | Atrial Natriuretic Peptide(ANP)(1-28) |
≥98% | | 询价 |
| 38 | 550997-55-2 | ERB-196(WAY-202196) |
≥98% | | 询价 |
| 39 | 145733-36-4 | Tasosartan |
≥98% | | 询价 |
| 40 | 796854-35-8 | WAY-204688(SIM-688) |
≥98% | | 询价 |
| 41 | 581-88-4 | Debrisoquin sulfate |
≥98% | | 询价 |
| 42 | 54739-21-8 | Clovoxamine fumarate |
≥98% | | 询价 |
| 43 | 98206-09-8 | Eltoprazine HCl |
≥98% | | 询价 |
| 44 | 133025-23-7 | Way 100135 |
≥98% | | 询价 |
| 45 | 145743-63-1 | WAY127093B racemate |
≥98% | | 询价 |
| 46 | 220460-92-4 | WAY-151932 |
≥98% | | 询价 |
| 47 | 428868-32-0 | WAY-163909 |
≥98% | | 询价 |
| 48 | 1431697-74-3 | CAL-130 |
≥98% | | 询价 |
| 49 | 1235449-52-1 | BEBT-908 |
≥98% | | 询价 |
| 50 | 1332075-63-4 | PI3kδinhibitor 1 |
≥98% | | 询价 |
| 51 | 1101810-02-9 | AZD3147 |
≥98% | | 询价 |
| 52 | 1949802-49-6 | PI3K/mTOR Inhibitor-1 |
≥98% | | 询价 |
| 53 | 1013098-90-2 | PI3Kα/mTOR-IN-1 |
≥98% | | 询价 |
| 54 | 1848242-58-9 | PI3K/mTOR Inhibitor-2 |
≥98% | | 询价 |
| 55 | 1245319-54-3 | PI4KIII beta inhibitor 3 |
≥98% | | 询价 |
| 56 | 2242109-74-4 | PI3Kdelta inhibitor 1 |
≥98% | | 询价 |
| 57 | 137945-48-3 | Ajulemic acid |
≥98% | | 询价 |
| 58 | 851627-62-8 | PR-104 |
≥98% | | 询价 |
| 59 | 1216920-18-1 | BIBX 1382 diHCl |
≥98% | | 询价 |
| 60 | 1235560-31-2 | ABT-639 HCl |
≥98% | | 询价 |
m.cnreagent.com